用溴苄铵进行人体心脏的化学性心室除颤。 - Suppr

Chemical ventricular defibrillation of the human heart with bretylium tosylate.

作者信息

Sanna G, Arcidiacono R

出版信息

Am J Cardiol. 1973 Dec;32(7):982-7. doi: 10.1016/s0002-9149(73)80168-7.

DOI:10.1016/s0002-9149(73)80168-7

PMID:4757239

Abstract

摘要

相似文献

Chemical ventricular defibrillation of the human heart with bretylium tosylate.

Am J Cardiol. 1973 Dec;32(7):982-7. doi: 10.1016/s0002-9149(73)80168-7.

Bretylium tosylate for suppression of ventricular fibrillation after experimental myocardial infarction.

Nature. 1968 Nov 2;220(5166):494-6. doi: 10.1038/220494a0.

Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate.

Am J Cardiol. 1968 Apr;21(4):530-43. doi: 10.1016/0002-9149(68)90286-5.

[Bretylium tosylate in the treatment and prevention of ventricular arrhythmia: a new look at an old drug].

Pol Tyg Lek. 1988 Oct 31;43(44):1415-8.

[Test of the prevention of ventricular fibrillation by bretylium. Preliminary note].

Arch Mal Coeur Vaiss. 1968 Jul;61(7):982-92.

Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.

Heart Lung. 1980 Mar-Apr;9(2):265-70.

Prevention of ventricular fibrillation during hypothermia with bretylium tosylate.

Anesth Analg. 1971 Jul-Aug;50(4):587-93.

Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.

J Pharmacol. 1986 Jul-Sep;17(3):223-43.

[Bretylium tosylate and ventricular hyperexcitability in myocardial infarct].

G Ital Cardiol. 1972;2(1):163.

Bretylium tosylate.

Am Heart J. 1971 Nov;82(5):703-6. doi: 10.1016/0002-8703(71)90341-3.

引用本文的文献

Factors determining spontaneous ventricular defibrillation.

Exp Clin Cardiol. 2001 Summer;6(2):109-13.

The protective effect of D-sotalol against hypoxia-induced myocardial uncoupling.

Heart Vessels. 1996;11(6):281-8. doi: 10.1007/BF01747187.

Antifibrillatory effects of clofilium in the rabbit isolated heart.

Br J Pharmacol. 1994 Sep;113(1):209-15. doi: 10.1111/j.1476-5381.1994.tb16195.x.

The role of catecholamines on intercellular coupling, myocardial cell synchronization and self ventricular defibrillation.

Mol Cell Biochem. 1995;147(1-2):181-5. doi: 10.1007/BF00944799.

New antiarrhythmic drugs: their place in therapy.

Drugs. 1981 Nov;22(5):363-400. doi: 10.2165/00003495-198122050-00002.

Clinical pharmacokinetics of bretylium.

Clin Pharmacokinet. 1985 May-Jun;10(3):248-56. doi: 10.2165/00003088-198510030-00004.

Potassium channel blockade: A mechanism for suppressing ventricular fibrillation.

Proc Natl Acad Sci U S A. 1986 Apr;83(7):2223-7. doi: 10.1073/pnas.83.7.2223.

Pharmacological analysis of established ventricular fibrillation.

Br J Pharmacol. 1990 Jul;100(3):530-4. doi: 10.1111/j.1476-5381.1990.tb15841.x.

Determinants of successful transthoracic defibrillation and outcome in ventricular fibrillation.

Br Heart J. 1991 Jun;65(6):311-6. doi: 10.1136/hrt.65.6.311.

Torsades de pointes: arrhythmia, syndrome, or chimera? A perspective in the light of the Lambeth Conventions.

Cardiovasc Drugs Ther. 1991 Feb;5(1):191-200. doi: 10.1007/BF03029820.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Chemical ventricular defibrillation of the human heart with bretylium tosylate.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献